The Role of Anesthetic Drugs and Statins in Prostate Cancer Recurrence: Starting at the Actual Knowledge and Walking through a New Paradigm
暂无分享,去创建一个
J. L. Guerrero Orriach | A. Raigon Ponferrada | Juan Carlos Molina Ruiz | S. Romero Molina | Verónica Rodriguez Garcia
[1] A. Jemal,et al. Cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.
[2] S. Mashele,et al. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches , 2022, Molecules.
[3] W. Hwang,et al. Perioperative Inflammatory Response and Cancer Recurrence in Lung Cancer Surgery: A Narrative Review , 2022, Frontiers in Surgery.
[4] Yuzhuo Wang,et al. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention , 2022, Journal of experimental & clinical cancer research : CR.
[5] Qi-Dong Xia,et al. Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies , 2022, Frontiers in Oncology.
[6] A. Kaye,et al. The Influence of Analgesic Modalities on Postoperative Cancer Recurrence , 2022, Anesthesiology and pain medicine.
[7] Qingfeng Hu,et al. The association of statin use and biochemical recurrence after curative treatment for prostate cancer , 2022, Medicine.
[8] D. Berney,et al. What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment , 2021, International journal of molecular sciences.
[9] J. Cruz Mañas,et al. Breast Cancer and Anaesthesia: Genetic Influence , 2021, International journal of molecular sciences.
[10] S. Yun,et al. Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial , 2021, Clinical Cancer Research.
[11] Jing Yang,et al. Propofol enhanced the cell sensitivity to paclitaxel (PTX) in prostatic cancer (PC) through modulation of HOTAIR , 2021, Genes & Genomics.
[12] Chao Ma,et al. Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway , 2021, International journal of molecular medicine.
[13] D. Ma,et al. Anesthetics may modulate cancer surgical outcome: a possible role of miRNAs regulation , 2021, BMC Anesthesiology.
[14] W. Nahas,et al. Opioids and premature biochemical recurrence of prostate cancer: a randomised prospective clinical trial. , 2021, British journal of anaesthesia.
[15] T. Kinoshita,et al. Links between Inflammation and Postoperative Cancer Recurrence , 2021, Journal of clinical medicine.
[16] J. Hallas,et al. Inhalation or total intravenous anaesthesia and recurrence after colorectal cancer surgery: a propensity score matched Danish registry-based study. , 2020, British journal of anaesthesia.
[17] G. Sethi,et al. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway , 2020, Journal of cellular physiology.
[18] A. Tsung,et al. Surgical Stress Promotes Tumor Progression: A Focus on the Impact of the Immune Response , 2020, Journal of clinical medicine.
[19] H. Hua,et al. Complex roles of cAMP–PKA–CREB signaling in cancer , 2020, Experimental Hematology & Oncology.
[20] M. Kao,et al. Anesthesia and Long-Term Oncological Outcomes: A Systematic Review and Meta-analysis. , 2020, Anesthesia and analgesia.
[21] A. Figueiredo,et al. Statins Prevent Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Single-center Retrospective Study with a Median Follow-up of 51.20 Months , 2020, Research and reports in urology.
[22] K. Ng,et al. Effect of perioperative regional anesthesia on cancer recurrence: A meta-analysis of randomized controlled trials. , 2020, International journal of surgery.
[23] A. Lenis,et al. The Role of Opioids and Their Receptors in Urologic Malignancy: A Review. , 2020, The Journal of urology.
[24] V. Koyyala,et al. The tumor microenvironment , 2020, Current Biology.
[25] James D. Murphy,et al. Associations among statins, preventive care, and prostate cancer mortality , 2020, Prostate Cancer and Prostatic Diseases.
[26] Na Young Kim,et al. Comparison of Biochemical Recurrence After Robot-assisted Laparoscopic Radical Prostatectomy with Volatile and Total Intravenous Anesthesia , 2020, International journal of medical sciences.
[27] B. Herrera Imbroda,et al. Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia , 2020, Oncology.
[28] Gonghui Li,et al. lncRNA UCA1 Functions as a ceRNA to Promote Prostate Cancer Progression via Sponging miR143 , 2019, Molecular therapy. Nucleic acids.
[29] E. Mascha,et al. Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial , 2019, The Lancet.
[30] D. Siemens,et al. Anesthetic technique and oncological outcomes in urology: A clinical practice review. , 2019, Urologic oncology.
[31] D. Ma,et al. Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review. , 2019, British journal of anaesthesia.
[32] M. Kao,et al. Comment on “Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia” , 2019, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[33] D. Ma,et al. Can Anesthesia Influence Cancer Outcomes After Surgery? , 2019, JAMA surgery.
[34] Ł. Łaczmański,et al. Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response , 2019, Front. Genet..
[35] B. Riedel,et al. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia , 2019, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[36] Yue Yu,et al. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog In Vitro , 2019, Oxidative medicine and cellular longevity.
[37] Yang Wang,et al. Propofol inhibits proliferation, migration and invasion of gastric cancer cells by up-regulating microRNA-195. , 2018, International journal of biological macromolecules.
[38] Hu Zhao,et al. Positive surgical margin is associated with biochemical recurrence risk following radical prostatectomy: a meta-analysis from high-quality retrospective cohort studies , 2018, World Journal of Surgical Oncology.
[39] Sufang Jiang,et al. Effects of propofol on cancer development and chemotherapy: Potential mechanisms , 2018, European journal of pharmacology.
[40] J. Qian,et al. Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α , 2018, BioMed research international.
[41] Jai-hyun Hwang,et al. Comparison of the effect of spinal anesthesia and general anesthesia on 5-year tumor recurrence rates after transurethral resection of bladder tumors , 2017, Oncotarget.
[42] N. Terada,et al. Effect of propofol on androgen receptor activity in prostate cancer cells , 2017, European journal of pharmacology.
[43] Hailin Zhao,et al. Local anesthetic bupivacaine induced ovarian and prostate cancer apoptotic cell death and underlying mechanisms in vitro , 2016, Scientific Reports.
[44] Yan Qian,et al. CD4+CD25+ regulatory T cells in tumor immunity. , 2016, International immunopharmacology.
[45] A. Raval,et al. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis , 2016, Prostate Cancer and Prostatic Diseases.
[46] J. Karam,et al. Regional anesthesia/analgesia and the risk of cancer recurrence and mortality after prostatectomy: a meta-analysis. , 2015, Pain management.
[47] G. Scheffer,et al. A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models , 2015, Pain.
[48] G. Strichartz,et al. Cancer surgery: how may anesthesia influence outcome? , 2015, Journal of clinical anesthesia.
[49] M. Narita,et al. κ Opioid receptor ligands regulate angiogenesis in development and in tumours , 2015, British journal of pharmacology.
[50] T. Schlomm,et al. Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter? , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[51] M. Terris,et al. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: Results from the SEARCH database , 2014 .
[52] T. Murtola. Statins and biochemical recurrence after radical prostatectomy – who benefits? , 2014, BJU international.
[53] D. Schroeder,et al. Outcomes After Radical Prostatectomy for Cancer: A Comparison Between General Anesthesia and Epidural Anesthesia with Fentanyl Analgesia A Matched Cohort Study , 2014, Anesthesia and analgesia.
[54] P. Scardino,et al. Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study , 2014, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.
[55] A. Masson-Lecomte,et al. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. , 2014, European urology.
[56] R. Brown,et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination , 2014, British Journal of Cancer.
[57] L. Bergkvist,et al. The choice of anaesthetic—sevoflurane or propofol—and outcome from cancer surgery: A retrospective analysis , 2014, Upsala journal of medical sciences.
[58] D. Schroeder,et al. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. , 2014, British journal of anaesthesia.
[59] R. Salgia,et al. Increased μ-opioid receptor expression in metastatic lung cancer. , 2014, British journal of anaesthesia.
[60] Ji-Xin Cheng,et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. , 2014, Cell metabolism.
[61] Christopher L. Wu,et al. Spinal Anesthesia Does Not Impact Prostate Cancer Recurrence in a Cohort of Men Undergoing Radical Prostatectomy: An Observational Study , 2014, Regional Anesthesia & Pain Medicine.
[62] D. Ma,et al. Isoflurane, a Commonly Used Volatile Anesthetic, Enhances Renal Cancer Growth and Malignant Potential via the Hypoxia-inducible Factor Cellular Signaling Pathway In Vitro , 2013, Anesthesiology.
[63] F. Burkhard,et al. Epidural Analgesia during Open Radical Prostatectomy Does Not Improve Long-Term Cancer-Related Outcome: A Retrospective Study in Patients with Advanced Prostate Cancer , 2013, PloS one.
[64] B. Beck-Schimmer,et al. Volatile Anesthetics Reduce Invasion of Colorectal Cancer Cells through Down-regulation of Matrix Metalloproteinase-9 , 2012, Anesthesiology.
[65] M. Srougi,et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer , 2012, BMC Urology.
[66] R. Salgia,et al. Overexpression of the &mgr;-Opioid Receptor in Human Non-Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis , 2012, Anesthesiology.
[67] T. Kessler,et al. Potential Influence of the Anesthetic Technique Used during Open Radical Prostatectomy on Prostate Cancer-related Outcome: A Retrospective Study , 2010, Anesthesiology.
[68] P. Boutros,et al. Dysregulation of the mevalonate pathway promotes transformation , 2010, Proceedings of the National Academy of Sciences.
[69] D. Schopflocher,et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy , 2010, Canadian journal of anaesthesia = Journal canadien d'anesthesie.
[70] E. Mascha,et al. Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrence: A Retrospective Analysis , 2008, Anesthesiology.
[71] Craig Murdoch,et al. The role of myeloid cells in the promotion of tumour angiogenesis , 2008, Nature Reviews Cancer.
[72] T. Tammela,et al. Cholesterol-Lowering Drugs and Prostate Cancer Risk: A Population-based Case-Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[73] K. Cho,et al. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR‐mediated Akt and ERK signal transduction , 2007, The Prostate.
[74] E. Mascha,et al. Can Anesthetic Technique for Primary Breast Cancer Surgery Affect Recurrence or Metastasis? , 2006, Anesthesiology.
[75] H. Welch,et al. Statins and the Risk of Colorectal Cancer , 2005, The New England journal of medicine.
[76] Ronit Almog,et al. Statins and the risk of colorectal cancer. , 2005, The New England journal of medicine.
[77] T. Hla,et al. Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[78] T G Cotter,et al. Excisional surgery for cancer cure: therapy at a cost. , 2003, The Lancet. Oncology.
[79] M. Minden,et al. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis , 2002, Leukemia.
[80] S B Malkowicz,et al. Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .
[81] A. Renshaw,et al. Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .
[82] E. Castanas,et al. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. , 1997, European journal of pharmacology.
[83] Lyndsay T Wilson,et al. Observational Study , 2019, Encyclopedia of Behavioral Medicine.
[84] S. Spampinato,et al. Opioid Receptors , 2015, Methods in Molecular Biology.
[85] G. Batist,et al. Use of statins and the risk of death in patients with prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] J. McDonald,et al. Opioid Receptors , 2015, Methods in Molecular Biology.
[87] E. Compérat,et al. Guidelines on Muscle-invasive and Metastatic Bladder Cancer , 2013 .
[88] R. Salgia,et al. Overexpression of the -Opioid Receptor in Human Non- Small Cell Lung Cancer Promotes Akt and mTOR Activation, Tumor Growth, and Metastasis , 2012 .
[89] T. Hla,et al. Role of prostaglandin E 2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression , 2004 .
[90] C. Schaffner. Prostatic cholesterol metabolism: regulation and alteration. , 1981, Progress in clinical and biological research.